Abstract

For rapid screening and quantification of an antisera antibody, a nanometer bithiophene-based conductive biolinker can enhanced signal performance and can be used to verify the interaction of an anti-IFN-γ antibody with an IFN-γ protein. The experimental measurements take a generic approach which takes advantage of the functionality of thiophene-based linkers for biosensors. Effects associated with using bithiophene as a biolinker for surface plasmon resonance (SPR) spectroscopy are examined in this paper. By using an atomic force microscope (AFM), it was observed that the morphology of the bithiophene modified gold sensor surface became smoother than the original gold surface. We compared the response and concentration of the anti-IFN-γ antibody on a bithiophene-coated and dextran-coated biochip as well as on different thickness-modified surfaces under SPR relevant conditions. The results indicate that a response to IFN-γ molecules immobilized on a sensor using a bithiophene biolinker improved more than 8-fold when compared to that of a sensor using a dextran biolinker. Furthermore, the regeneration ability of the sensor surface shows good repeatability as only less than a 1% decrease was found after repeating the experimental work over 6 cycles. The characteristics provided us with a good platform for rapid screening, real-time monitoring and quantitative concentration of the autoimmune antibody activities.

Highlights

  • For early prevention and treatment of diseases, clinical symptoms with a particular diagnosis and other tests can help to identify a specific disease and identify its mechanism

  • The simulation results were obtained from the reflection rate difference between the bithiophene-coated and dextran-coated chip at different incident angles and sample thicknesses in Morphology of Bithiophene Modified Gold Surface

  • All of the results shown above indicates that an Au-bithiophene biolinker modified surface was smoother than that of a bare gold layer

Read more

Summary

Introduction

For early prevention and treatment of diseases, clinical symptoms with a particular diagnosis and other tests can help to identify a specific disease and identify its mechanism. Quantifying an unusual biomarker in the blood or body fluids is useful for patients suspected of having a disease. There are many types of biomarkers which include proteins, cytokine, chemokine, auto-antibodies, etc. Their concentration varies among the specific biomolecule.

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.